Skip to main content
. 2020 Jan 21;10:3137. doi: 10.3389/fimmu.2019.03137

Figure 3.

Figure 3

Glioma EVs mediate immunomodulation. Glioma EVs induce an M2 phenotype in tumor associated myeloid cells and cause T cell dysfunction. Arg1, arginase-1; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein 1; TGF-β, Transforming growth factor-β; PD-L1, programmed cell death 1 ligand.